BRIEF published on 05/21/2026 at 14:59, 10 days 11 hours ago The Vanguard Group Discloses Position in Tate & Lyle plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Tate & Lyle
BRIEF published on 05/21/2026 at 14:59, 10 days 11 hours ago Vanguard Group Discloses Position in Spire Healthcare Form 8.3 Vanguard Group Spire Healthcare Shareholding Disclosure UK Takeover Code
BRIEF published on 05/21/2026 at 14:58, 10 days 11 hours ago The Vanguard Group Discloses Position in Schroders plc Form 8.3 Takeover Code Schroders Plc Vanguard Group Shareholding
BRIEF published on 05/21/2026 at 14:57, 10 days 11 hours ago The Vanguard Group Discloses Position in NCC Group plc The Vanguard Group Takeover Code Securities Disclosure Equity Holdings NCC Group Plc
BRIEF published on 05/21/2026 at 14:57, 10 days 11 hours ago The Vanguard Group, Inc.: Disclosure of Interests in JTC plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group JTC Plc
BRIEF published on 05/21/2026 at 14:56, 10 days 11 hours ago Vanguard Group Discloses Position in International Personal Finance Form 8.3 Takeover Code Vanguard Group Public Disclosure International Personal Finance
BRIEF published on 05/21/2026 at 14:55, 10 days 11 hours ago The Vanguard Group Discloses Position on Gamma Communications Takeover Code Vanguard Group Shareholding Regulatory Disclosure Gamma Communications
PRESS RELEASE published on 05/21/2026 at 14:54, 10 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses a 4.73% interest in Tate & Lyle plc. Form 8.3 filed under Rule 8.3 of the Takeover Code Form 8.3 Rule 8.3 Takeover Code Vanguard Group Tate & Lyle Plc
PRESS RELEASE published on 05/21/2026 at 14:54, 10 days 11 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% interest in Spire Healthcare Group plc in a Form 8.3 filing as of 20 May 2026 Securities Form 8.3 Disclosure Vanguard Group Spire Healthcare
BRIEF published on 05/21/2026 at 14:54, 10 days 11 hours ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Takeover Code Securities Disclosure Vanguard Group Share Purchase Bluefield Solar
Published on 05/30/2026 at 04:00, 1 day 22 hours ago Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 1 day 23 hours ago BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 2 days ago Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 2 days 1 hour ago Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 2 days 3 hours ago The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 05/31/2026 at 00:15, 1 day 2 hours ago Take Your Shot & Make Your Moment: OPPO Ignites Football Culture with Technology at the UEFA Champions League Final
Published on 05/30/2026 at 19:35, 1 day 6 hours ago THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Published on 05/30/2026 at 17:10, 1 day 9 hours ago MakerWorld's First User-Initiated Charity Contest Names Winners, Bringing Global Creators' Goodwill Directly to Cancer Wards
Published on 05/29/2026 at 21:42, 2 days 4 hours ago EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 2 days 4 hours ago Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 22:00, 2 days 4 hours ago Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 2 days 8 hours ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 12:00, 2 days 14 hours ago Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 2 days 15 hours ago bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market
